Overview

Dapagliflozin in Patients With Critical Illness: A Randomized Controlled Trial

Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
To assess the effects of dapagliflozin on a composite hierarchical endpoint in critically ill patients.
Phase:
Phase 3
Details
Lead Sponsor:
Hospital Israelita Albert Einstein
Treatments:
Dapagliflozin